SCHEMBL7258476

SCHEMBL7258476

CCOC(CCC(=O)O)OCC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRP O00591 2/20 0.50
GABRD O14764 2/20 0.50
GABRA1 P14867 2/20 0.50
GABRB1 P18505 2/20 0.50
GABRG2 P18507 2/20 0.50
GABRB3 P28472 2/20 0.50
GABRA5 P31644 2/20 0.50
GABRA3 P34903 2/20 0.50
GABRA2 P47869 2/20 0.50
GABRB2 P47870 2/20 0.50
GABRA4 P48169 2/20 0.50
GABRE P78334 2/20 0.50
GABRA6 Q16445 2/20 0.50
GABRG1 Q8N1C3 2/20 0.50
GABRG3 Q99928 2/20 0.50
GABRQ Q9UN88 2/20 0.50
CYP1A2 P05177 2/20 0.44
FFAR3 O14843 1/20 0.42
HDAC3 O15379 1/20 0.42
HDAC1 Q13547 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29035549 0.98 GABRP (0.48) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL7930896 0.89 GABRP (0.45) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL7925069 0.87 AKR1B1 (0.42) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL9517412 0.86 AKR1B1 (0.44) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL25694176 0.85 FFAR4 (0.50) AKR1B1FFAR4LMNAFFAR1ALDH1A1
SCHEMBL28513621 0.83 FFAR4 (0.48) AKR1B1FFAR4LMNAFFAR1ALDH1A1
SCHEMBL27969304 0.83 FFAR4 (0.53) AKR1B1FFAR4LMNAFFAR1ALDH1A1
SCHEMBL28758843 0.83 GABRP (0.34) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL28556062 0.82 FFAR3 (0.44) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL11785584 0.81 ALDH1A1 (0.41) GABRPGABRDGABRA1GABRB1GABRG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112694608-B Six-arm polyethylene glycol derivative, preparation method and modified biological related substance 厦门赛诺邦格生物科技股份有限公司 2024-07-02 CN disclosed
CN-115010915-B Nitrogen-branched nine-arm polyethylene glycol derivative, preparation method and modified biologically-relevant substance thereof 厦门赛诺邦格生物科技股份有限公司 2024-06-11 CN disclosed
CN-111542557-B Conjugated diene rubber 日本瑞翁株式会社 2023-03-28 CN disclosed
CN-112119118-B Rubber composition for tire tread and pneumatic tire 横滨橡胶株式会社 2023-03-10 CN disclosed
CN-112166149-B Rubber composition for winter tire tread and winter pneumatic tire 横滨橡胶株式会社 2023-02-28 CN disclosed
CN-112119117-B Rubber composition for tire tread and pneumatic tire 横滨橡胶株式会社 2023-02-21 CN disclosed
CN-112135873-B Rubber composition for tire tread and pneumatic tire 横滨橡胶株式会社 2023-02-17 CN disclosed
CN-115698172-A Rubber composition for tire and tire 横滨橡胶株式会社 2023-02-03 CN disclosed
CN-115667397-A Rubber composition for tire and tire 横滨橡胶株式会社 2023-01-31 CN disclosed
CN-114436809-B Method for preparing diethyl maleate by carrying out depolymerization on lignin under catalysis of iron oxide loaded by USY molecular sieve 华南理工大学 2023-01-06 CN disclosed
US-20180273595-A1 ERG TARGETED THERAPY THE REGENTS OF THE UNIVERSITY OF MICHIGAN 2018-09-27 US disclosed
WO-2018175273-A1 ERG TARGETED THERAPY THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2018-09-27 WO disclosed
US-20180214561-A1 EIGHT-ARM POLYETHYLENE GLYCOL DERIVATIVE, PRODUCTION METHOD THEREFOR, AND MODIFIEDBIO-RELATEDSUBSTANCETHEREOF XIAMEN SINOPEG BIOTECH CO., LTD. (CN) 2018-08-02 US disclosed
EP-3315531-A1 8-ARM POLYETHYLENE GLYCOL DERIVATIVE, MANUFACTURING METHOD AND MODIFIED BIO-RELATED SUBSTANCE THEREBY Xiamen Sinopeg Biotech Co., Ltd. (CN) 2018-05-02 EP disclosed
CN-1897931-A Inhibitors of cathepsin s IRM LLC (BM) 2007-01-17 CN disclosed
EP-1067935-B1 ACYLBENZOXAZINES FOR ENHANCING SYNAPTIC RESPONSE(S) UNIV CALIFORNIA (US) 2003-08-20 EP disclosed
EP-1067935-A4 ACYLBENZOXAZINES FOR ENHANCING SYNAPTIC RESPONSE(S) UNIV CALIFORNIA (US) 2001-10-04 EP disclosed
EP-1067935-A1 ACYLBENZOXAZINES FOR ENHANCING SYNAPTIC RESPONSE(S) The Regents of the University of California (US) 2001-01-17 EP disclosed
US-6124278-A COGNITION ACTIVATORS FOR LEARNING/MEMORY ENHANCEMENT AND TREATMENT OF BRAIN/PSYCHOLOGICAL DISORDERS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2000-09-26 US disclosed
WO-1999051240-A1 ACYLBENZOXAZINES FOR ENHANCING SYNAPTIC RESPONSE(S) THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1999-10-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180214561-A1 EIGHT-ARM POLYETHYLENE GLYCOL DERIVATIVE, PRODUCTION METHOD THEREFOR, AND MODIFIEDBIO-RELATEDSUBSTANCETHEREOF MRPL38, CXCL8, ALG8 GABRP 1197/4885GABRD 1277/4885GABRA1 862/4885
US-20180273595-A1 ERG TARGETED THERAPY ERG, EWSR1, ETV1 GABRP 2584/4885GABRD 1836/4885GABRA1 2968/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.